Tag: LAA

Analysis of LAA closure devices reveals post-approval spike in safety events

  A retrospective study conducting a safety assessment and comparison between two percutaneous devices commonly used for left atrial appendage (LAA) closure in the US­...

Europace 2017: Thrombus formation on left atrial appendage occlusion devices strongly...

A French multicentre analysis of left atrial appendage (LAA) occlusion for stroke prevention in atrial fibrillation patients has found a 5.3% rate of thrombus...

HRS 2017: Watchman prevents stroke even in high-risk patients: One-year follow-up...

Left atrial appendage closure with the Watchman device (Boston Scientific) is safe and effective at stroke prevention, with a high implant and sealing success,...

First Texas centre uses St Jude Medical Amplatzer Amulet

The Texas Cardiac Arrhythmia Institute at St David's Medical Center,  Austin, USA became the first facility in the US state of Texas to implant...

AF Symposium 2017: Use of intracardiac echocardiography is a “viable option”...

Intracardiac echocardiograpy (ICE) facilitates a high success implant rate of the Amplatzer Amulet left atrial appendage (LAA) occluder (St Jude Medical/Abbott) as well as...

AHA 2016: Transcatheter atrial shunt benefits persist through one year in...

Twelve-month results of the REDUCE LAP HF (Reduce elevated left atrial pressure in patients with heart failure) trial have shown both continued device patency...

Charity believes NHS programme will leave hundreds of atrial fibrillation patients...

Arrhythmia Alliance, the UK-based heart rhythm charity, is calling on NHS England to reconsider a programme that it says will mean the “hundreds” of...

Commissioning through evaluation for LAAO in England

Dhiraj Gupta (Liverpool Heart and Chest Hospital, Liverpool, UK) discusses NHS England's commissioning through evaluation for left atrial appendage occlusion (LAAO). This programme is...

SentreHEART announces first clinical use of the Eclipse surgical left atrial...

  SentreHEART has announced it has treated the first patients using the Eclipse surgical device for left atrial appendage (LAA) closure. Krzysztof Bartus (Jagiellonian University,...

No significant differences between Watchman and Amplatzer in first comparison

Results from the first study to compare outcomes of two left atrial appendage closure devices—Watchman (Boston Scientific) and Amplatzer (St Jude Medical)—indicate that there...

St Jude Medical launches trial of Amplatzer Amulet left atrial appendage...

The St Jude Medical Amplatzer Amulet Investigational Device Exemption (IDE) trial, which will evaluate the safety and effectiveness of the company’s Amplatzer Amulet left...

Educational supplement: LAA closure for stroke prophylaxis in atrial fibrillation

This educational supplement is only for readers in countries outside France, Japan and the USA In this educational supplement, sponsored by Boston Scientific, Cardiac Rhythm News explores left...

CE mark granted to Occlutech left atrial appendage occluder

Occlutech has obtained European CE mark approval for its left atrial appendage, (LAA), occluder. The device is a specifically designed implant for the minimally...